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Neurodevelopmental outcome following 
therapeutic hypothermia for perinatal 
asphyxia
Smail Zubčević, Suada Heljić, Raho Spahović, Ismeta Kalkan, Sabina Terzić, Mirna Sadiković*
Studies are supporting neuroprotective benefi t of therapeutic hypothermia in term newborns with hypoxic-ischemic encephalo-
pathy. We assessed survival and neurodevelopmental outcome of neonates subjected to the procedure and factors that may have 
infl uenced it. Newborns with gestational age of more than 36 weeks and less than 6 hours of age with moderate to severe asphyxial 
encephalopathy underwent cooling protocol at a temperature of 33.5 °C for 72 hours and rewarming period of 6 hours. The outcome 
measures assessed were death and neurodevelopmental characteristics. Twenty-fi ve children were assessed during the period from 
October 2010 to October 2013. Median gestational age was 40 weeks, birth weight 3470 g, Apgar score 2/4 and pH on admission to 
the hospital 7.02. Four (16%) children died and two were lost for follow up. At the age of fi nal assessment, developmental categories 
of communication were normal in 68.4%, problem solving in 73.7%, personal-social in 68.4%, gross motor in 57.9%, and fi ne motor 
in 36.8% but with a high need of retesting in this area. Seven of 19 patients (36.8%) had completely normal results for all fi ve catego-
ries, while three (15.8%) had abnormal results for all categories. None of the 18 parameters that were correlated with neurodevelop-
mental outcome showed statistical signifi cance. Amplitude integrated electroencephalography was done in ten patients and the 
most prominent fi nding was discontinuous activity in eight patients. In conclusion, a relatively small number of patients and limita-
tions of this study design precluded any far-reaching conclusions, but we think that this method can provide better survival and less 
neurologic sequels in hypoxic-ischemic encephalopathy patients.
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INTRODUCTION
Hypoxic-ischemic encephalopathy (HIE) is a major cause of 
morbidity and mortality in neonates despite important 
progress in obstetric and neonatal care during the last dec-
ades. According to Lawn et al. (1), it is the fi fth most com-
mon cause of death in children under 5 years. Perinatal as-
phyxia aff ects 3-5 newborns per 1000 live births with subse-
quent moderate or severe hypoxic ischemic encephalopathy 
in 0.5 to 1 per 1000 live births in developed countries (2). 
These numbers are twice or more in developing countries 
(3). Studies show that 10% to 60% of aff ected infants die, 
and at least 25% of survivors have long-term neurodevelop-
mental sequels (4).
Therapeutic approach for treating neonatal encephalopa-
thy has to be based on the understanding of the mecha-
nisms of neuronal damage following hypoxic-ischemic 
brain injury. That pathway is probably our clue for fi nding 
the best possibilities for preventing brain injury in asphyxi-
ated neonates. Animal models show that many factors play 
a role, e.g., etiology, extent of hypoxia or ischemia, matura-
tion stage of the brain, regional cerebral blood fl ow, and 
general health prior to the injury can all impact the pattern 
and extent of brain injury as well as outcome following the 
injury (5). Results of previous studies on this subject indicate 
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that some other factors can play additional role, especially 
in developing countries, such as maternal nutrition, infec-
tions, late admission to hospital, lengthy decision making 
for cesarean section, etc. Today, general understanding of 
the pathophysiological processes in HIE is that the initial hy-
poxic-ischemic insult brings immediate cell loss of varying 
degrees, but delayed impairment in energy metabolism 
leads to more signifi cant cell loss by apoptotic cell death.
One of the ideas to try ameliorating this secondary brain 
injury is by putting neonates at risk of developing moderate 
to severe HIE on therapeutic hypothermia. A review of ani-
mal studies showed that brain cooling to 32 °C to 34 °C, 
beginning before 5.5 hours following hypoxic-ischemic in-
jury and continued for 12-72 hours, reduced secondary en-
ergy failure and cell death and was associated with neu-
ropathological and functional improvements (6). Several 
human trials in which cooling was initiated as early as feasi-
ble after brain injury (but before 6 hours) and in which ne-
onates rectal/esophageal temperature was reduced to 32 
°C to 34 °C showed promising results. The potential mecha-
nisms of neuroprotection with hypothermia include inhibi-
tion of glutamate release, reduction of cerebral metabolism, 
which in turn preserves high energy phosphates, decrease 
in intracellular acidosis and lactic acid accumulation, preser-
vation of endogenous antioxidants, reduction of nitric ox-
ide production, prevention of protein kinase inhibition, im-
provement of protein synthesis, reduction of leukotriene 
production, prevention of blood-brain barrier disruption 
and brain edema, and inhibition of apoptosis (7, 8). Rand-
omized controlled trials such as the CoolCap study (9), Na-
tional Institute for Child Health and Human Development 
(NICHD) Neonatal Research Network (10), TOBY Trial (11) 
and ICE Trial (12) have led to a growing number of centers 
around the world deciding to make this procedure part of 
their routine work. Two major diff erent methods are pre-
sent today: whole-body cooling (nowadays prevailing) and 
selective head cooling (less used). There is no mutual con-
sensus if one of these is superior, and debate is still going 
on (13).
In this study, we tried to assess the outcome of children 
treated with therapeutic hypothermia for moderate and se-
vere perinatal asphyxia, as well as the infl uence of several 
factors presented at admission to the hospital and discharge 
from the hospital on neurodevelopmental outcome.
PATIENTS AND METHODS
We assessed neurodevelopmental outcome of 25 children 
at diff erent age, which were after birth treated with thera-
peutic hypothermia. Infants were eligible for consideration 
of such a treatment if they were born at or after 36 com-
pleted weeks of gestation.
Protocols for selecting patients for therapeutic hypothermia 
treatment were revised from TOBY study and so called Bris-
tol Cooling Protocol (14-16). Revisions were made in a way 
that criteria for inclusion in hypothermia treatment by per-
forming amplitude-integrated electroencephalography 
(aEEG) read by trained personnel were not obligatory if oth-
er criteria were met, and aEEG was done only in several pa-
tients.
This meant that infants with more than 36 weeks of gesta-
tion, and with at least one of the following: Apgar score ≤5 
at ten minutes after birth, continued need for resuscitation, 
including endotracheal or mask ventilation at 10 minutes 
after birth, acidosis defi ned as either umbilical cord pH or 
any arterial, venous or capillary pH within 60 min of birth 
less than 7.00, or base defi cit greater than or equal to 16 
mmol/L in umbilical cord blood sample or any blood sam-
ple within 60 minutes of birth (arterial or venous blood), 
were eligible for further evaluation for cooling. Next criteria 
were moderate to severe encephalopathy, consisting of al-
tered state of consciousness (lethargy, stupor or coma), and 
at least one or more of the following: persistent hypotonia 
after successful resuscitation, abnormal refl exes including 
oculomotor or pupillary abnormalities, absent or weak suck, 
and clinical seizures as recorded by trained personnel. Chil-
dren who meet these criteria largely correspond to stage II 
and III of Sarnat grading scale of HIE.
Only three infants in this group were studied by aEEG prior 
to cooling process, for at least 30 minutes duration, and 
 another seven were monitored during cooling process. 
aEEG was assessed as: with continuous, normal background 
voltage without electrical seizure activity, moderately ab-
normal voltage (upper margin of trace >10μV and lower 
margin of trace <5μV), discontinuous, suppressed activity 
(upper margin of trace <10μV and lower margin of trace 
<5μV, and for seizure activity. aEEG was done with Nicolet 
ICU Monitor (CareFusion Corporation, San Diego, California, 
USA); four electrodes were placed in the P3-P4 and C3-C4 
areas, fi fth electrode (neutral electrode) was placed to the 
front of the midline as a ground for noise immunity place-
ment of electrodes.
Cooling duration was 72 hours, with at least 6 hours of re-
warming. Rectal temperatures were set to 33.5 °C. Cooling 
was performed by the Arctic Sun Temperature Manage-
ment System (Medivance, Louisville, Colorado, USA) as a 
thermoregulatory device that monitors and controls patient 
temperature within a range of 32 °C to 38.5 °C. The system 
consists of the Model 2000 and disposable Arctic Gel hydro-
gel coated pads. Cooling and rewarming was done in a pre-
programmed way.
Mortality was ascertained up to the latest follow up. Chil-
dren were followed-up for their neurodevelopment through 
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We were able to get ASQ-3 questionnaires for 19 of our pa-
tients at the time of fi nishing our follow up and their neu-
rodevelopmental outcome according to the results from 
ASQ-3 questionnaires is presented in Table 3.
It is worth noting that seven of 19 patients (36.8%) had 
completely normal results for all fi ve categories, while three 
(15.8%) had abnormal results for all categories. We tried to 
assess whether some of the parameters that were recorded 
at birth as well as during the recruiting process for thera-
peutic hypothermia and during hospital stay had any cor-
relation with neurodevelopmental outcome. There was no 
statistically signifi cant correlation between these parame-
ters and neurodevelopmental outcome. Results are shown 
in Table 4.
We also tried to see if some features from neurological ex-
amination of the child on discharge from the hospital after 
therapeutic hypothermia for perinatal asphyxia could be 
correlated with outcome, and whether scoring these ex-
aminations (0 point - Abnormal, 1 point - Normal) could be 
helpful in predicting neurodevelopmental outcome. We did 
not fi nd any statistically signifi cant correlation. Results are 
shown in Table 5.
Ten children in our group were monitored by aEEG, three 
prior and during, and seven only during therapeutic hypo-
thermia. A prominent fi nding in eight of these patients was 
discontinuous background activity as described before, and 
two had a burst suppression pattern during recording. 
DISCUSSION
The lack of specifi c interventions to improve frequently 
poor prognosis of neonates with moderate to severe peri-
TABLE 1. Baseline characteristics of infants treated with therapeutic 
hypothermia for perinatal asphyxia
Male/Female 13/12
Gestational age (wks, range) 37-42
Gestational age (wks, median) 40
Birth weight (g, range) 2220-4950
Birth weight (g, median) 3470
Head circumference (cm, range) 33-37
Head circumference (cm, median) 35
Apgar score at 1/5 minutes (range) 0/5-1/6
Apgar score at 1/5 minutes (median) 2/4
Age at starting cooling (hours, range) 2-8
Age at starting cooling (hours, median) 4
pH at admission to hospital (range) 6.49-7.25
pH at admission to hospital (median) 7.02
Resuscitation required at 10 min of age, n (%) 22 (88)
Clinical seizures prior to cooling, n (%) 12 (48)
regular visits at child neurology outpatient clinic, through a 
structured examination by one trained assessor. At the mo-
ment of fi nishing study, cross-sectional evaluation of their 
development was done by the parent and assistant, com-
pleting questionnaires based on the Ages & Stages Que-
stionnaires (ASQ-3), adopted in a way described by Kapci et 
al. (17), and use it as part of the project of introducing early 
intervention programs in Bosnia and Herzegovina. We de-
cided to base our neurodevelopmental assessment on this 
parent-completed developmental and social-emotional 
screener questionnaire because of its highly valid, reliable 
and accurate results that span across the spectrum of ages, 
since we did not have enough patients in the age group 
above 18 or 24 months. ASQ shows sensitivity of 92%, 95% 
specifi city, 92% positive predictive value and 95% negative 
predictive value when used to detect severe developmen-
tal delay; and 67% sensitivity, 93% specifi city, 92% positive 
predictive value and 68% negative predictive value when 
used to detect both severe and mild developmental delay 
in children with neonatal HIE (18). It has very good correla-
tion with more sophisticated, time consuming tests, like 
Bayley scale, which require investigators’ thorough educa-
tion (19). Parents were instructed to fi ll in the questionnaire 
during follow up visit. In the period of assessment, children 
were aged 4-36 months.
The IBM SPSS 20 software package was used for statistical 
analyses; descriptive statistics was used for description of 
the variables, means, medians, ranges and distribution of 
data. Mann-Whitney U Test was used to show signifi cance 
of independent variables in relation to dependent (neu-
rodevelopmental outcome). Linear regression was tested.
RESULTS
The study was conducted from October 2010 to October 
2013 at Pediatric Hospital, Sarajevo University Clinical Cent-
er, Sarajevo, Bosnia and Herzegovina. Children were recruit-
ed for the study from two maternity hospitals in Sarajevo 
and 9 other diff erent maternity hospitals in Bosnia and 
Herzegovina.
Compliance with the protocol was not complete in two pa-
tients, where cooling started after the age of 6 hours, due to 
decision of doctors on ward at that time. Baseline charac-
teristics of the infants are shown in Table 1.
Patient outcome, survival and age at testing according to 
categories of communication, gross motor, fi ne motor, 
problem solving, and personal-social skills for each of our 
patients treated with therapeutic hypothermia for perinatal 
asphyxia are shown in Table 2. Four (16%) patients died and 
two (8%) were lost during follow up, but with no indication 
that they died.
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natal asphyxia had made neonatologists eager to try novel 
treatments. Hypoxic-ischemic encephalopathy presents a 
huge problem for later health care of those patients, carry-
ing signifi cant morbidity and mortality rates and leading to 
a signifi cant burden on society. In the last decade, one of 
the most promising new treatments has been therapeutic 
hypothermia for perinatal asphyxia.
Since this method is in widespread use in the world for less 
than 5 years, randomized trials are still scarce, and data from 
them are sometimes contradictory. A recent meta-analysis 
(18), however, states that it strongly supports the use of 
therapeutic hypothermia in newborns with HIE to reduce 
the risk of death and neurologic impairment at 18 months. 
But some other studies still show that a lot of things regard-
ing therapeutic hypothermia have to be answered, and 
possibly, adjusting of therapy should be done in the com-
ing years (19).
Nowadays, many medical centers are starting ‘cooling pro-
grams’, not only in highly developed countries, but also in 
developing countries. Results from less developed coun-
tries do not always correlate with those in highly developed 
countries, due to several reasons, and for this problem we 
have to put accent on factors such as maternal nutrition, 
scope of prenatal and perinatal infections, less developed 
medical transport services, lack of adequate hospital facili-
ties, late admission to hospital and lengthy decision making 
for cesarean section, etc. That is why we tried to compare 
the results from Bosnia and Herzegovina with the results 
from other highly developed countries.
Our sample for the past three years was quite small and 
neurodevelopmental follow up frequently not long enough 
to make far-reaching conclusions. Our mortality rate for the 
followed period, four out of 25 patients (16%), was compa-
rable or lower than in most other studies (9-12). From the 
available data, it is hard to comment on this, since there was 
no major diff erence in asphyxia severity, and our percent-
age can be part of a small number of patients we had in our 
group.
TABLE 2. Outcome of patients treated with therapeutic hypothermia for perinatal asphyxia
No. Age at testing(months) Communication Gross Motor Fine Motor Problem Solving Personal-Social
 1 20 Normal Normal Normal Normal Normal
 2 8 Normal Normal Normal Normal Normal
 3 12 Normal Normal Normal Normal Normal
 4 Died
 5 4 Normal Hemiparesis Hemiparesis Normal Normal
 6 4 Normal Normal Normal Normal Normal
 7 n/a n/a n/a n/a n/a n/a
 8 8 Normal Normal Normal Normal Normal
 9 27 Normal Normal Normal Normal Normal
10 4 Normal Normal Retesting Retesting Abnormal
11 36 Normal Hemiparesis Hemiparesis Normal Normal
12 22 Abnormal Abnormal Abnormal Abnormal Abnormal
13 12 Normal Hemiparesis Retesting Normal Normal
14 22 Abnormal Normal Abnormal Normal Retesting
15 Died
16 4 Abnormal Normal Abnormal Abnormal Abnormal
17 36 Normal Normal Retesting Normal Normal
18 Died
19 Died
20 24 Normal Normal Normal Normal Normal
21 4 Normal Retesting Retesting Normal Normal
22 n/a n/a n/a n/a n/a n/a
23 20 Abnormal Abnormal Abnormal Abnormal Abnormal
24 27 Retesting Retesting Retesting Normal Normal
25 16 Abnormal Abnormal Abnormal Abnormal Abnormal
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neurodevelopmental examinations performed by child 
neurologists and psychologists. The simplicity of the ques-
tionnaire makes it very aff ordable for less developed child 
health care systems, but the results are probably not as well 
defi ned as with more sophisticated tools, such as Bayley 
Scale of Infant Development.
Duration of follow up was one of the issues of this study 
because all our patients were not followed up for the same 
time. There are no studies showing how long follow up pe-
riod is needed for more accurate prediction of neurodevel-
opmental follow up in these children, and common sense 
would be that it should be as long as possible, but Azzop-
ardi et al. (2012) found in their study that there were no sig-
nifi cant diff erences in clinical characteristics, aEEG prior to 
cooling, and age in hours after birth when cooling was 
started between the infants with and without 2-year out-
come data available (20).
On the part of gross and fi ne motor development we had 
little less good results. About 31% of children were having 
clearly abnormal gross motor development (half of them 
with hemiparesis) and further 10% were in retesting zone. 
Some 26% of our group had abnormal fi ne motor develop-
TABLE 5. Statistical signifi cance of correlation between neurodevelopmental outcome and some neurological 
fi ndings at discharge from the hospital
At discharge Plantar grasp refl ex
Palmar grasp 
refl ex Muscle tone Moro refl ex Overall score
Asymp. sig. (2-tailed) 0.392 0.360 0.316 0.204 0.207
Exact sig. (1-tailed sig.) 
Not corrected for ties
0.522 0.446 0.410 0.292 0.235
TABLE 3. Neurodevelopmental outcome according to results of the Ages & Stages Questionnaires (ASQ-3)
Communication Gross Motor Fine Motor Problem Solving Personal - Social




5 (26,31%) 4 (21,05%) 5 (26,31%)
Retesting zone 1 (5,26%) 2 (10,53%) 7 (36,84%) 1 (5,26%) 1 (5,26%)
Total 19 19 19 19 19
TABLE 4. Correlation of diff erent parameters with neurodevelopmental 
outcome (level of statistical signifi cance)
Asymp. Sig. 
(2-tailed)
Exact Sig. (1-tailed Sig.)
(Not corrected for ties)
Age (weeks) 0.093 0.131
Birth Weight (range) 0.336 0.343
pH Prior to Hypothermia 
(range)
0.756 0.784
Base Excess (range) 0.852 0.879
Seizures Prior to Hypothermia 
(Yes/No)
0.858 0.879
Haematocrit (numeric) 0.828 0.832
Hemoglobin (numeric) 0.687 0.693
Platelet count (numeric) 0.652 0.738
Period Between Birth And 
Starting Hypothermia (hours)
0.612 0.648
Hypoglycaemia (Yes/No) 0.189 0.284
C-reactive protein (CRP) 0.316 0.410
Sepsis (Yes/No) 0.171 0.376
Seizures During Hypothermia 
(Yes/No)
0.519 0.605
Initial Brain Ultrasound 
(Normal/Abnormal)
0.192 0.343
Developmental outcome was also similar, with good results 
on regular neurodevelopmental follow up examinations. 
That was confi rmed by the results obtained through ASQ-3. 
The results were really encouraging in the domains of com-
munication, problem solving and personal-social perform-
ances, with normal behavior in about 70% of patients. Test-
ing the reliability of ASQ-3 in these conditions, regarding 
the issues of sensitivity, specifi city, positive predictive value, 
negative predictive value, interobserver reliability remains 
uncertain (17), but we had good correlation with structured 
ment, but with further 37% of children in retesting zone. All 
these results are quite comparable to the studies mentioned 
above. 
TOBY report (11) fi nds 27% of patients with severe neurode-
velopmental disability in cooled group, and survival without 
neurologic abnormality in 44%. They also fi nd a normal GM-
FCS score in 71%, which is somehow higher than our results. 
All those follow ups were quite short and we need longer 
periods, as a meta-analysis from 2010 states: “Continued fol-
low up of the children enrolled in the studies included in our 
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meta-analysis is essential to determine whether these ben-
efi ts are maintained in later childhood” (18).
Prior to starting cooling, during cooling and after it we re-
corded numerous parameters. We tried to see if some of 
them had any kind of correlation with neurodevelopmental 
outcome, but statistical methods used were restricted by a 
small number of patients in our group. We were not able to 
show that any of the studied parameters had statistically 
signifi cant infl uence on neurodevelopmental outcome, 
even the neurological examination at discharge from the 
hospital. We think that for such studies, much larger groups 
of patients are needed, and we need to have more multi-
center studies dealing with this matter. Not too many stud-
ies have addressed this problem until now. Wyatt et al. (21) 
on a much larger sample of 218 children found a correlation 
of developmental outcome with treatment, lower enceph-
alopathy grade, lower birth weight, greater aEEG amplitude, 
absence of seizures, and higher Apgar score, with better 
outcomes for children with these parameters. Bennet et al. 
(22) make a good point in emphasizing the need for better 
understanding of the potential role of biomarkers for HIE.
The need to perform aEEG before starting cooling, in the 
process of recruitment of candidates for therapeutic hypo-
thermia for perinatal asphyxia remains one of greater con-
troversies in this method. At the beginning of follow up 
period, our hospital did not have aEEG equipment, and we 
only had it for the last year of our work. In a recent prospec-
tive study (23), the authors found that the aEEG background 
pattern at <9 hours did not signifi cantly enhance the pre-
dictive value of HIE stage at <6 hours in predicting death 
and disability at 18 months. Other researchers investigated 
the abilities of aEEG recordings during cooling and found 
that the recovery of the background pattern within 24 hours 
was associated with a lower rate of disability (defi ned as 
death, cerebral palsy, or developmental quotient <85) at 2 
years (24), and that the time to normalize aEEG was a better 
predictor than the time to establish normal sleep-wake cy-
cling (25). On the other hand, some large randomized trials 
included aEEG recordings in the recruitment process for 
therapeutic hypothermia to prevent HIE (11, 15, 16).
From the perspective of our limited experience and fi rst 
steps in applying therapeutic hypothermia for perinatal as-
phyxia, we think that the results we are getting are highly 
promising. Our relatively small number of patients and limi-
tations of study design (not a randomized, controlled study) 
make our conclusions less reliable, but we think that this 
can be a solid base for starting assessing the eff ects of ther-
apeutic hypothermia in countries with limited health care 
resources. This study shows that improved managing of pa-
tients at risk of severe HIE can aff ect morbidity and mortality 
rates in less developed countries where this problem is 
much more present. 
Abbreviations:
HIE – hypoxic-ischemic encephalopathy
aEEG – Amplitude Integrated Electroencephalography
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S A Ž E T A K
Neurorazvojni ishod nakon terapijske hipotermije 
zbog perinatalne asfi ksije
S. Zubčević, S. Heljić, R. Spahović, I. Kalkan, S. Terzić, M. Sadiković
Rezultati raznih ispitivanja govore u prilog neuroprotektivnom učinku terapijske hipotermije u terminske novorođenčadi s hipoksič-
no-ishemijskom encefalopatijom. Mi smo procjenjivali preživljenje i neurorazvojni ishod novorođenčadi podvrgnute ovom postupku 
te čimbenike koji bi mogli imati utjecaja na taj ishod. Postupak pothlađivanja na temperaturi od 33,5 ºC kroz 72 sata te 6-satno 
razdoblje utopljavanja primijenjen je kod novorođenčadi gestacijske dobi više od 36 tjedana i manje od 6 sati života s umjerenom do 
teškom asfi ksijskom encefalopatijom. Ispitivane mjere ishoda bile su smrt i neurorazvojne značajke. Od listopada 2010. do listopada 
2013. godine procijenjeno je 25 djece, medijan gestacijske dobi 40 tjedana, porođajna masa 3470 g, APGAR 2/4 i pH kod prijma u 
bolnicu 7,02. Četvero (16%) djece je umrlo, a dvoje je izgubljeno tijekom razdoblja praćenja. U dobi konačne procjene razvojne kate-
gorije komunikacije bile su normalne u 68,4%, rješavanja problema u 73,7%, osobne-socijalne u 68,4%, grube motorike u 57,9% i fi ne 
motorike u 36,8% djece, ali uz izraženu potrebu ponovnog testiranja u ovom području. Sedmero od 19 (36,8%) bolesnika imalo je 
potpuno normalne razultate u svih pet kategorija, dok su nenormalni razultati u svih pet kategorija zabilježeni u troje (15,8%) bole-
snika. Nijedan od 18 parametara koji su korelirani s neurorazvojnim ishodom nije se pokazao statistički značjanim. Elektroencefalo-
grafi ja integrirane amplitude provedena je u desetoro bolesnika, a najizraženiji nalaz bila je isprekidana aktivnost u osmero bole-
snika. Zaključno, relativno mali broj bolesnika i ograničenja ove studije ne dopuštaju nikakve dalekosežnije zaključke, ali smatramo 
da ova metoda može osigurati bolje preživljenje i manje neuroloških posljedica kod bolesnika s hipoksično-ishemijskom encefalopa-
tijom.
Ključne riječi: perinatalna asfi ksija hipotermija; novorođenče
